IAT0981 1A8
Alternative Names: IAT0981-1A8Latest Information Update: 08 Jun 2022
Price :
$50 *
At a glance
- Originator SUNHO (China) BioPharmaceutical
- Class Antineoplastics; Immunotherapies; Single-domain antibodies
- Mechanism of Action Regulatory T-lymphocyte inhibitors; Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer